Adamis Pharmaceuticals Corporation   Report issue

For profit Phase 2 Phase 3
Founded: San Diego CA United States (2006)
Status: No NME R&D (2006)

Organization Overview

First Clinical Trial
2011
NCT01436214
First Marketed Drug
2017
epinephrine (levophed)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Adamis Pharmaceutical Corporation | Adamis Pharmaceuticals Corporation | ADAMIS PHARMS CORP